More recently, studies have shown that remoteness was associated with increased duration of hospitalization in the last year of life for dementia patients in WA [29] and lower prescription rates of cholinesterase inhibitors for Alzheimer’s Disease in WA [30], highlighting possible inequities in levels of care for people with dementia in rural and remote areas. This evidence concerns the gene BCHE and early-onset autosomal dominant Alzheimer disease.